Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × lenvatinib × 30 days × Clear all

Phase

Status

Recruiting 15 Active not recruiting 8 Not yet recruiting 6 Completed 3 Terminated 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 1

Interventions

pembrolizumab 11 Nivolumab 7 Carboplatin 6 Specimen Handling 5 Pemetrexed 5 Interviews as Topic 5 Biopsy 5 venetoclax 4 fludarabine 4 durvalumab 4 X-Rays 4 Paclitaxel 4 Magnetic Resonance Spectroscopy 4 Gemcitabine 4 Drug Therapy 4 Cyclophosphamide 4 Cisplatin 4 olaparib 3 binimetinib 3 atezolizumab 3 Surveys and Questionnaires 3 Radiotherapy 3 Radiosurgery 3 Prednisone 3 Docetaxel 3 toripalimab 2 tislelizumab 2 tazemetostat 2 spartalizumab 2 regorafenib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06114940 2026-03-05

PLUTO

Jinling Hospital, China

Phase 2 Terminated

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡